Burmester, G-R
Stiftung Charité · Charité – Universitätsmedizin Berlin
12 papers on CoChatORCID 0000-0001-7518-1131
Most cited papers
- Verified
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders
Cited by 544
- Verified
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods
Cited by 305
- Verified · note
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
Listing, J., Kekow, J., Manger, B., Burmester, G.-R., Pattloch, D., Zink, A., & Strangfeld, A. (2015) · Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 295
- Verified
Preactivated Peripheral Blood Monocytes in Patients With Essential Hypertension
Dörffel, Y., Lätsch, C., Stuhlmüller, B., Schreiber, S., Scholze, S., Burmester, G. R., & Scholze, J. (1999) · Hypertension
Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies
Cited by 262
- Verified
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
Burmester, G. R., Rigby, W. F., van Vollenhoven, R. F., Kay, J., Rubbert-Roth, A., Kelman, A., Dimonaco, S., & Mitchell, N. (2016) · Annals of the Rheumatic Diseases
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 194
- Verified
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
Burmester, G. R., Buttgereit, F., Bernasconi, C., Álvaro-Gracia, J. M., Castro, N., Dougados, M., Gabay, C., van Laar, J. M., Nebesky, J. M., Pethoe-Schramm, A., et al. (2020) · The Lancet
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research
Cited by 128
- Verified
Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls
Jacobi, A. M., Goldenberg, D. M., Hiepe, F., Radbruch, A., Burmester, G. R., & Dörner, T. (2008) · Annals of the Rheumatic Diseases
Systemic Lupus Erythematosus ResearchT-cell and B-cell Immunology
Cited by 127
- Verified
Exogenous and endogenous glucocorticoids in rheumatic diseases
Buttgereit, F., Burmester, G., Straub, R. H., Seibel, M. J., & Zhou, H. (2011) · Arthritis & Rheumatism
Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders
Cited by 105
- Verified
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+ flux upon activation
Sieger, N., Fleischer, S. J., Mei, H. E., Reiter, K., Shock, A., Burmester, G. R., Daridon, C., & Dörner, T. (2013) · Arthritis & Rheumatism
T-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research
Cited by 61
- Verified
Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
Avci, A. B., Feist, E., & Burmester, G. R. (2024) · BioDrugs
Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods
Cited by 50
- Verified
Adaptation of Human CD4+ T Cells to Pathophysiological Hypoxia: A Transcriptome Analysis
GABER, T., HÄUPL, T., SANDIG, G., TYKWINSKA, K., FANGRADT, M., TSCHIRSCHMANN, M., HAHNE, M., DZIURLA, R., EREKUL, K., LAUTENBACH, M., et al. (2009) · The Journal of Rheumatology
Rheumatoid Arthritis Research and TherapiesCancer, Hypoxia, and Metabolism
Cited by 47
- Verified
Human CD4+Tcells maintain specific functions even under conditions of extremely restricted ATP production
Tripmacher, R., Gaber, T., Dziurla, R., Häupl, T., Erekul, K., Grützkau, A., Tschirschmann, M., Scheffold, A., Radbruch, A., Burmester, G., et al. (2008) · European Journal of Immunology
T-cell and B-cell ImmunologyCancer, Hypoxia, and Metabolism
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free